| 临床特征 | CR率(%) | P值 |
| 性别 |
| 0.300 |
| 男 | 80.61 (79/98) |
|
| 女 | 86.42 (70/81) |
|
| 年龄(岁) |
| <0.01 |
| ≤1或 ≥10 | 65. 63 (21/32) |
|
| 1~10 | 87.07 (128/147) |
|
| WBC (×109/L) |
| <0.01 |
| ≤10 | 90.57 (96/106) |
|
| 10~100 | 80.00 (48/60) |
|
| ≥100 | 46.13 (6/13) |
|
| LDH (U/L) |
| 0.020 |
| ≤500 | 89.38 (101/113) |
|
| 500~1000 | 77.42 (24/31) |
|
| ≥1000 | 70.59 (24/34) |
|
| SF (ng/mL) |
| 0.305 |
| ≤450 | 86.72 (111/128) |
|
| > 450 | 80.43 (37/46) |
|
| 融合基因 |
|
|
| BCR-ABL1 | 60.00 (3/5) |
|
| TEL-AML1 | 76.92 (30/39) |
|
| E2A-PBX1 | 75.00 (6/8) |
|
| MLLr | 50.00 (2/4) |
|